Similar articles

• Expanding indications for cardiac MIBG imaging of sympathetic activity.

  Carrió I, Flotats A. Carrió I, et al. Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):219-20. doi: 10.1007/s00259-010-1650-7. Eur J Nucl Med Mol Imaging. 2011. PMID: 20978759 No abstract available.
• Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus.

  Schnell O, Muhr D, Weiss M, Kirsch CM, Haslbeck M, Tatsch K, Standl E. Schnell O, et al. J Diabetes Complications. 1997 Sep-Oct;11(5):307-13. doi: 10.1016/s1056-8727(97)00015-9. J Diabetes Complications. 1997. PMID: 9334913
• Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.

  Langer A, Freeman MR, Josse RG, Armstrong PW. Langer A, et al. J Am Coll Cardiol. 1995 Mar 1;25(3):610-8. doi: 10.1016/0735-1097(94)00459-4. J Am Coll Cardiol. 1995. PMID: 7860904
• Cardiac sympathetic imaging with mIBG in heart failure.

  Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Carrió I, et al. JACC Cardiovasc Imaging. 2010 Jan;3(1):92-100. doi: 10.1016/j.jcmg.2009.07.014. JACC Cardiovasc Imaging. 2010. PMID: 20129538 Review.
• Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG.

  Giordano A, Calcagni ML, Verrillo A, Pellegrinotti M, Frontoni S, Spallone V, Gambardella S. Giordano A, et al. Diabetes Nutr Metab. 2000 Dec;13(6):350-5. Diabetes Nutr Metab. 2000. PMID: 11232761 Review.